Story
Tripadvisor Stock Falls After BTIG Downgrade on AI Concerns

Summary
Shares of the online travel company declined after BTIG lowered its rating to Neutral from Buy, citing risks from artificial intelligence eroding the platform's search traffic and a lack of clear strategic catalysts.
Shares of Tripadvisor (NASDAQ: TRIP) fell sharply in pre-market trading after analysts at BTIG downgraded the stock to Neutral from a Buy rating, citing significant risks posed by artificial intelligence and a lack of clear strategic direction.
Analyst Downgrade Cites AI Threat
BTIG's rating change, issued Monday evening, removed a key bullish voice on the stock and was the primary catalyst for the decline. The firm's core concern is Tripadvisor's vulnerability to the rise of generative AI in search, which threatens the company's traditional role as a top-of-funnel destination for travel planning.
According to the analyst note, AI-driven overviews and "zero-click" search results are eroding the organic search traffic that has historically been a major source of users for the Tripadvisor platform. BTIG also noted that large technology platforms are gaining traction as direct travel planning tools, creating a more challenging competitive landscape.
Lowered Estimates and Outlook
Alongside the downgrade, BTIG also lowered its second-half estimates for Tripadvisor to below Wall Street consensus levels. The firm pointed to several factors for the more cautious outlook:
Ad- Ongoing traffic headwinds at the core Tripadvisor brand.
- Mixed performance at its Viator experiences and bookings unit.
- An absence of clear pathways for the company to unlock additional strategic value.
Following the ratings change, analyst sentiment on Tripadvisor is now split, with 6 Buy, 7 Hold, and 4 Sell ratings, according to the source.
Market Reaction
The stock fell 3.5% in pre-open trading to $13.91, moving in contrast to a broader market rally. The move underscores that the weakness is company-specific rather than a reaction to macroeconomic factors. The shares remain significantly below their 52-week high of $20.16.
With the next earnings report not scheduled until August 6, the downgrade leaves investors with fewer potential near-term positive catalysts to offset the renewed skepticism about the company's long-term competitive positioning in an AI-driven market.
Read next
More on Stocks
Boeing and Gogo Test Satellite-Linked Drone as Starlink Alternative
Boeing's Insitu and Gogo have successfully tested a military drone using Eutelsat OneWeb's satellite network, creating an ITAR-free alternative that challenges SpaceX's Starlink dominance in the defense sector.

InnovAge Stock Falls Sharply on 10 Million Share Secondary Offering
Shares of InnovAge plunged in after-hours trading after two major private equity backers, Apax Partners and Welsh, Carson, Anderson & Stowe, announced a secondary offering of 10 million shares.

Nasdaq Gains While Dow Slips in Mixed U.S. Trading Session
U.S. equities finished a divided session on Tuesday, with the tech-heavy Nasdaq Composite gaining while the Dow Jones Industrial Average fell, driven by losses in financial and energy stocks.

TriSalus Life Sciences Stock Soars on FDA Clearance for New Drug Delivery Device
Shares of TriSalus Life Sciences (NASDAQ: TLSI) jumped 29% after the U.S. Food and Drug Administration granted 510(k) clearance for its TriNav Advance device, expanding its portfolio for targeted cancer therapies.